Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the aging population, and no disease-modifying therapy has been approved to date. The pathogenesis of PD has been related to many dysfunctional cellular mechanisms, however, most of its monogenic forms are caused by pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahya, Vidal, Di Fonzo, Alessio, Monfrini, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094484/
https://www.ncbi.nlm.nih.gov/pubmed/37047309
http://dx.doi.org/10.3390/ijms24076338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094484/
https://www.ncbi.nlm.nih.gov/pubmed/37047309
http://dx.doi.org/10.3390/ijms24076338

Ejemplares similares